Rapid drug test to provide patients with better care
Teams at two of Melbourne's leading research and medical institutes are developing high-tech solutions to rapidly test for drugs and better treat patients presenting to hospital.
Jul 5, 2024
0
38
MeSH tree: E05.601
Teams at two of Melbourne's leading research and medical institutes are developing high-tech solutions to rapidly test for drugs and better treat patients presenting to hospital.
Jul 5, 2024
0
38
Even though COVID-19 manifests as a mild and short-lived disease in most people, some suffer extremely severe symptoms; in the worst cases, these patients die due to complications such as respiratory failure or thromboembolism. ...
Jun 19, 2024
0
31
Researchers at UNIST have developed an innovative device designed for precise diagnosis of sleep apnea, utilizing a smartphone application in the convenience of one's own home.
Jun 12, 2024
0
42
Vitamin D tests certified by the U.S. Centers for Disease Control and Prevention (CDC) Clinical Standardization Programs (CSP) are well calibrated overall, according to a new study presented at ENDO 2024, the Endocrine Society's ...
Jun 3, 2024
0
17
A research group in Japan has established a microfluidic control technology that can be applied to small blood testing devices and consequently developed a novel integrated immunoassay device. This microfluidic control technology ...
May 28, 2024
0
47
A simple, safe and accurate test that identifies women with womb cancer from a sample taken from the vagina has been developed by clinician scientists from The University of Manchester.
Mar 21, 2024
0
52
Rice University researchers have developed a rapid, accurate test for diagnosing malaria that is significantly faster and easier to use than traditional tests. The advancement has the potential to improve patient outcomes, ...
Feb 29, 2024
0
32
When SARS-CoV-2 enters the human body, the virus' spike protein binds to a cell, allowing the virus to infiltrate and begin replicating.
Jan 24, 2024
0
59
The Dana Farber Cancer Institute in Boston will retract six studies and correct 31 more as part of an ongoing investigation into claims of data manipulation.
Jan 23, 2024
1
50
Researchers have studied the association of proprotein convertase subtilisin/kexin type 9 (PCSK9) with soluble P-selectin (sP-selectin) and their values in predicting major adverse cardiovascular events (MACE) at one-year ...
Jan 8, 2024
0
27